Innovation
We’re reshaping how healthcare is delivered by investing in our industry’s innovators and building solutions to support them.
To create healthier futures, we have to look ahead
Our central role in the pharmaceutical supply chain gives us the opportunity to work across the care continuum, gaining valuable insight into the challenges being faced today, as well as what’s ahead. That in-depth understanding, when combined with our purpose and evolving knowledge of market trends, is what drives us to not only further innovation for the sake of improving current-day customer experiences, but also pave the way for more efficient healthcare delivery for years to come. Envisioning a better future is integral to our leadership and our dedication to partnering with innovators to bring cutting-edge solutions to care providers and expand access to therapies, pharmaceuticals, and healthcare products.
Investing in the future
We support the growth of leading-edge entrepreneurial businesses through Cencora Ventures, a $150 million corporate venture fund investing in emerging healthcare startup companies. The fund, and the dedicated team behind it, invest in and provide commercial support to emerging healthcare startup companies to help them maintain scalability as they grow.
Expanding our suite of solutions
We’re developing new offerings and making enhancements to our existing solutions to meet the needs of our customers today and tomorrow. For our pharmaceutical partners, that includes everything from commercialization strategy to clinical trial support so we can help them launch new therapies, enter untapped markets, and reach more people. For providers, we take a forward-thinking approach to prepare them for shifting market dynamics through data and analytics capabilities, business coaching, inventory management, legislative advocacy, and much more.
Applying process to progress
We have a dedicated team focused exclusively on creating best-in-class products and solutions. They gather ideas from all levels and all corners of the company and then use a rigorous stage gate process to design and test the best of the best. This enables us to continuously develop fresh concepts that have the potential to create healthier futures for our communities and drive new value for our customers, all while sparking innovation throughout our enterprise.
“Foundational to Cencora’s strategy and growth goals is the ability to effectively create, manage, and launch new products and services. Our team of dedicated experts is focused on developing and scaling new products and solutions that address some of our customers' greatest challenges.”
Jason Dinger
SVP, Global Products and Solutions
Jason Dinger
SVP, Global Products and Solutions
Optimizing the supply chain of the future
In addition to making ongoing investments to continuously improve the efficiency of our distribution services, we’re integrating new technologies and solutions to accommodate the complexities that tomorrow’s biopharmaceuticals will bring.
Unlocking the potential of emerging therapies and treatments
New advances are being made in medicine every day, and our goal is to facilitate those innovations by ensuring the patients who need them have access. This is especially complicated for specialty therapeutics like cell and gene, orphan, and oncology. Our expertise in these areas is helping us innovate in step with our partners.
"Cencora has a proven history of bringing complex and transformative therapies to market. But like our cell and gene therapy partners, we're always looking ahead. We want to innovate because there will be new challenges as the field evolves. We are committed to co-creating innovative solutions to meet those challenges."
Lung-I Cheng
VP, Cell and Gene Therapy
